Search results
Results from the WOW.Com Content Network
Covid-19 and its effect on the brain can be serious, researchers are learning. Studies continue to discover more on long-term Covid and how it impacts patients. New studies suggest Covid sneaks ...
About 20% of COVID-19 cases that pass through the intensive care unit (ICU) have chronic neurologic symptoms (beyond loss of smell and taste). [1] Of the patients that had an MRI , 44% had findings upon MRI, such as a FLAIR signal (fluid-attenuated inversion recovery signal), leptomeningeal spaces and stroke.
The overall brain volume in people with COVID-19 declined by an extra 0.3% over those without the disease. ... the coronavirus caused a loss of smell through a nonbrain-based mechanism and this ...
Symptoms of COVID-19. Some less common symptoms of COVID-19 can be relatively non-specific; however the most common symptoms are fever, dry cough, and loss of taste and smell. [1] [22] Among those who develop symptoms, approximately one in five may become more seriously ill and have difficulty in breathing.
A lobotomy (from Greek λοβός (lobos) 'lobe' and τομή (tomē) 'cut, slice') or leucotomy is a discredited form of neurosurgical treatment for psychiatric disorder or neurological disorder (e.g. epilepsy, depression) that involves severing connections in the brain's prefrontal cortex. [1]
(Reuters) - COVID-19 can cause the brain to shrink, reduce grey matter in the regions that control emotion and memory, and damage areas that control the sense of smell, an Oxford University study ...
In COVID-19, the arterial and general tissue oxygen levels can drop without any initial warning.The chest x-ray may show diffuse pneumonia.Cases of silent hypoxia with COVID-19 have been reported for patients who did not experience shortness of breath or coughing until their oxygen levels had depressed to such a degree that they were at risk of acute respiratory distress (ARDS) and organ failure.
The most recent COVID-19 vaccine should offer protection against the XEC variant, Russo says. “The most recent version of the vaccine seems to be reasonably well-matched,” he says.